Search

everythinglearnresearchcommunity

for

Search:↓

Alfredo Rebora suggested a new, easier way to classify hair loss in Telogen Effluvium, adding a type possibly related to autoimmune diseases.

People with Inflammatory Bowel Disease often lose hair due to stress, medication side effects, or lack of nutrients, and treatment depends on the specific cause.

The study found specific hair and scalp patterns for different types of hair loss in Koreans, noting racial differences affect diagnosis.

ULBP3 could be a marker for diagnosing alopecia areata incognita and may be linked to its cause and development.

Dengue fever can cause a temporary type of hair loss called telogen effluvium.

The paper suggests that telogen effluvium, a type of hair loss, may be a long-lasting condition triggered by stress or illness in people whose hair growth is unusually synchronized.

Some people with chronic hair loss may have thyroid autoimmunity.

Most patients with telogen effluvium had low iron and vitamin D levels; iron supplements were commonly prescribed.

Proteoglycans are important for hair growth, and a specific treatment can help reduce hair loss.

Hair loss in adult females in Makkah is often linked to iron-deficiency anemia and thyroid issues.

St. John's wort skin oil may increase skin damage risk during radiotherapy.

One supplement improved hair loss and quality faster and more effectively than the other in treating telogen effluvium.

Saw palmetto supplements may modestly improve hair regrowth with few side effects, but more research is needed.

Most patients experience temporary hair loss after ECMO, but it usually grows back within 6 months without treatment.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

Afro-textured hair is more fragile and prone to certain scalp conditions, requiring careful treatment and more research for effective management.

Telogen Effluvium is a common hair loss condition, particularly in women, with no specific FDA-approved treatment, and recovery can take up to 18 months.

Alfredo Rebora suggests a simpler classification for hair loss and a new test for easier diagnosis.

Telogen Effluvium is a common hair loss condition that can be short-term or long-lasting and is often caused by stress, illness, or nutritional issues.

Vitamin D may help with certain types of hair loss in women.

FAGA shows varied hair thickness, while TE has more empty follicles.

Telogen Effluvium (TE) significantly affects women due to stress and hormonal changes, requiring better public health policies and mental health support.

COVID-19 can cause significant hair loss.

COVID-19-related hair loss may have unique features compared to hair loss from other causes.

Trichoscopy is a useful, painless tool for diagnosing and monitoring children's hair and scalp issues.

Dietary supplements might help prevent post-COVID hair loss, but serum ferritin is not a reliable indicator.

Hair loss from Telogen Effluvium can be managed by treating the underlying cause and may improve with treatments like minoxidil.

Biomedical engineers are crucial for developing better treatments for chronic and autoimmune diseases.

COVID-19 can cause different types of hair loss, with telogen effluvium being the most common.

Ruxolitinib cream shows promise for vitiligo, and early melanoma diagnosis is crucial.